Aktiespot

United Orthopedic Corporation (UNITED ORTHOPEDIC CORPORATION) Aktie

4129.TWO

$89.70-0.60 (-0.66%)
Chart wird geladen...

UNITED ORTHOPEDIC CORPORATION

Eröffnung88.50
Hoch89.80
Tief86.80
Volumen325.87k
P/E15.82
Marktkapitalisierung8.65B
52-Wochen-Hoch131.50
52-Wochen-Tief86.80
Durchschn. Volumen329.38k
Dividende4.43%
BetaN/A
EPS5.67

Über United Orthopedic Corporation (UNITED ORTHOPEDIC CORPORATION) Aktie

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; spinal products comprising vertebral fixation devices; injury and other orthopedic products that consist of orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws; OEM products, such as orthopedic internal fixation; and limb salvage systems. It also provides orthopedic surgical equipment and its manufacturing equipment, as well as special metal and plastic materials. In addition, the company imports and exports its products and markets them through direct sales and distribution. The company was incorporated in 1993 and is headquartered in New Taipei City, Taiwan. United Orthopedic Corporation operates as a subsidiary of Chi-Yi Investment Co., Ltd.

Unternehmensinformationen

Börse: Taipei Exchange (TWO)
Sektor: Sundhed
Branche: Medicinsk udstyr
Adresse:
No.80, Sec.1, Chenggong Rd.
234634 New Taipei City, Taiwan
Telefon: + 886 2 2929 4567

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
123.00
37.1%
Durchschnittliches Kursziel
137.67
53.5%
Median Kursziel
132.00
47.2%
Höchstes Kursziel
158.00
76.1%

Andere sehen auch: